Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 39 sec ago

Endologix Announces Chief Financial Officer Transition

Thu, 03/12/2015 - 16:04
IRVINE, Calif., March 12, 2015 -- (Healthcare Sales & Marketing Network) -- Endologix, Inc. (ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief Financial Officer, has decided to resign fr...
Devices, Interventional, Personnel
Endologix, endovascular stent graft, abdominal aortic aneurysm

CryoLife Provides Update on PerClot Litigation

Thu, 03/12/2015 - 16:01
ATLANTA, March 12, 2015 -- (Healthcare Sales & Marketing Network) -- CryoLife, Inc. (CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, today provided an update on its ongoing litigation with C.R. Bard, I...
Devices, Surgery, Litigation
CryoLife, C.R. Bard, PerClot, hemostat

JACC Reports on First-In-Human Transcatheter Tricuspid Repair

Thu, 03/12/2015 - 15:55
Mitralign Transcatheter Annuloplasty System could present a non-surgical option for both mitral and tricuspid valve regurgitation TEWKSBURY, Mass.--(Healthcare Sales & Marketing Network)--A detailed reporting of the first successful case of a direct tra...
Devices, Interventional Cardiology
Mitralign, Transcatheter Annuloplasty, mitral regurgitation, tricuspid

Volcano receives CE mark for iFR Scout Pullback software to help diagnose serial lesions and diffuse coronary disease

Thu, 03/12/2015 - 15:52
AMSTERDAM and SAN DIEGO , March 12, 2015 (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG; AEX: PHIA), today announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software, a functional extension of ...
Devices, Interventional Cardiology, Regulatory
Royal Philips, Volcano, iFR Scout, Fractional Flow Reserve

Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England

Wed, 03/11/2015 - 22:18
CRAWLEY, England, March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced that it has been selected to equip and service two new national proton therapy centers in England with the Varian ProBeam® proto...
Devices, Oncology
Varian Medical Systems, proton therapy, ProBeam, radiotherapy

Cardiac Dimensions(R) Completes $43M Equity Financing

Wed, 03/11/2015 - 22:10
$15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations KIRKLAND, Wash., March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Cardiac Dimensions® today announc...
Devices, Cardiology, Venture Capital
Cardiac Dimensions, percutaneous mitral repair, CARILLON, mitral regurgitation

Pathway Genomics Appoints Former Cedars-Sinai Chair of Medicine Glenn D. Braunstein, M.D., as Chief Medical Officer

Wed, 03/11/2015 - 22:04
SAN DIEGO--(Healthcare Sales & Marketing Network)--Pathway Genomics Corporation, a forward-thinking big data healthcare company and global precision medicine clinical laboratory, has announced that endocrinologist Dr. Glenn D. Braunstein is the company’s n...
Diagnostics, Personnel
Pathway Genomics

Mylan Launches Generic Antabuse(R) Tablets

Wed, 03/11/2015 - 14:12
POTTERS BAR, England and PITTSBURGH, March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of Disulfiram Tablets USP, 250 mg and 500 mg, which is the generic version of Odyssey Pharmace...
Biopharmaceuticals, Generics, FDA
Mylan, Odyssey Pharmaceutical, Disulfiram, Antabuse

FDA Clearance for REZA BAND® UES Assist Device that Reduces Symptoms of Laryngopharyngeal Reflux (LPR)

Tue, 03/10/2015 - 16:19
Patients who suffer from symptoms of laryngopharyngeal reflux (LPR) may now find relief with this novel new medical device GERMANTOWN, Wis., March 10, 2015 -- (Healthcare Sales & Marketing Network) -- Somna Therapeutics today announced that the U.S. Fo...
Devices, Gastroenterology, FDA
Somna Therapeutics, REZA BAND, laryngopharyngeal reflux

Presbia Announces the Promotion of Dumitra Nela Gonzales to Vice President of Regulatory Affairs and Quality Assurance

Tue, 03/10/2015 - 15:49
DUBLIN--(Healthcare Sales & Marketing Network)--Presbia PLC (LENS), an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today that...
Devices, Ophthalmology, Personnel
Presbia, Flexivue Microlens, presbyopia

Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash

Tue, 03/10/2015 - 15:44
Significantly advances Cardinal Health's offering of interventional cardiology and endovascular solutions for integrated health systems and their patients Creates immediate global scale and scope Fiscal 2017, first full post-close year, accretion is ...
Devices, Interventional, Cardiology, Mergers & Acquisitions
Cardinal Health, Cordis

SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants

Mon, 03/09/2015 - 13:39
International Journal of Spine Surgery reports iFuse Implant System® provides superior clinical outcomes compared to non-surgical management in patients with SI joint dysfunction due to degenerative sacroiliitis or SI joint disruptions SAN JOSE, Cal...
Devices, Orthopaedic, Neurosurgery
SI-BONE, iFuse Implant System, spine surgery

Ceterix Announces Publication of Studies Demonstrating Advantages of Meniscus Repair With Minimally Invasive Orthopaedic Suturing Device

Fri, 03/06/2015 - 15:03
Technology Offers Potential to Improve Repairs, Extend Repair to Additional Tear Types MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue pr...
Devices, Orthopaedic
Ceterix Orthopaedics, NovoStitch, suture passer, Arthroscopy

Sunshine Heart Provides Update on U.S. Pivotal Study of C-Pulse(R) Heart Assist System

Fri, 03/06/2015 - 14:55
EDEN PRAIRIE, Minn., March 6, 2015 -- (Healthcare Sales & Marketing Network) -- Sunshine Heart, Inc. (SSH) today announced an update on COUNTER HF(TM), the Company's U.S. pivotal study which is a prospective, randomized, multi-center, controlled study eval...
Devices, Cardiology
Sunshine Heart, COUNTER HF, C-Pulse system, balloon counterpulsation

Second Sight Announces Successful First Implants of the Argus(R) II Retinal Prosthesis System at Two New Centers in Italy

Thu, 03/05/2015 - 13:24
SYLMAR, Calif.--(Healthcare Sales & Marketing Network)--Second Sight Medical Products, Inc. (Nasdaq: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind pat...
Devices, Ophthalmology
Second Sight Medical Products, Argus II, Retinal Prosthesis

Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel

Thu, 03/05/2015 - 13:16
WATERTOWN, Mass., March 5, 2015 -- (Healthcare Sales & Marketing Network) -- Tetraphase Pharmaceuticals, Inc. (TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, to...
Biopharmaceuticals, Personnel
Tetraphase Pharmaceuticals, eravacycline

Mazor Robotics Renaissance(R) Guidance System Helping Patients with OCD

Thu, 03/05/2015 - 13:12
ORLANDO, Fla., March 5, 2015 -- (Healthcare Sales & Marketing Network) -- Mazor Robotics (, a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery, announced today the f...
Devices, Neurosurgery
Mazor Robotics, Renaissance Guidance System, neurostimulator

CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer

Wed, 03/04/2015 - 14:00
ROCKVILLE, Md., March 4, 2015 -- (Healthcare Sales & Marketing Network) -- CASI Pharmaceuticals, Inc. (CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and othe...
Biopharmaceuticals, Personnel
CASI Pharmaceuticals

Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy

Wed, 03/04/2015 - 13:53
Bavarian Nordic to receive up to $975 million, inclusive of $60 million upfront and potential exercise payment; potential development, regulatory and commercialization milestone payments; additional tiered double-digit royalties on future sales KVISTGAA...
Biopharmaceuticals, Licensing, Oncology
Bristol-Myers Squibb, Bavarian Nordic, PROSTVAC, prostate cancer

Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors

Wed, 03/04/2015 - 00:35
MARLBOROUGH, Mass., March 3, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) announces the election of Charles J. Dockendorff and Stephen P. MacMillan to its board of directors, effective April 1, 2015. Two curr...
Devices, Personnel
Boston Scientific

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong